Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction

Blood

Volumn 94, Issue 3, 1999, Pages 1028-1037

  Bobé, Pierre ^a   Benihoud, Karim ^b   Grandjon, Danièle ^b   Opolon, Paule ^b   Pritchard, Linda Louise ^b   Huchett, Roger ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; ANTIBODY; CITRULLINE; GAMMA INTERFERON; LEUCINE METHYL ESTER; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; GENETIC TRANSCRIPTION; GRAFT VERSUS HOST REACTION; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MINOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME;

EID: 0033179327     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.1028.415k24_1028_1037     Document Type: Article

References (44)

1. Beatty PG, Hansen JA, Longton GM, Thomas ED, Sanders JE, Martin PJ, Bearman SI, Anasetti C, Petersdorf EW, Mickelson EM, Pepe MS, Appelbaum FR, Dean Buckner C, Clift RA, Petersen FB, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP: Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51:443, 1991
2. Bearman SI, Mori M, Beatty PG, Meyer WG, Buckner CD, Petersen FB, Sanders JE, Anasetti C, Martin P, Appelbaum FR, Hansen JA: Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors. Bone Marrow Transplant 13:31, 1994
3. Halle-Pannenko O, Pritchard LL, Motta R, Mathé G: Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells, Biomedicine 29:253, 1978
4. Korngold R, Sprent J: Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice: Prevention by removing mature T cells from marrow. J Exp Med 148:1687, 1978
5. Rappaport H, Khalil A, Halle-Pannenko O, Pritchard LL, Dantchev D, Mathé G: Histopathological sequence of events in the adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers. Am J Pathol 96:121, 1979
6. Motta R, Moutier R, Halle-Pannenko O: Minor histocompatibility genes important to lethal graft-versus-host reactions (GVHR): Chromosomal assignment of five genes using ten chromosomal markers. Transplant Proc 13:1207, 1981
7. Hamilton BL, Parkman R: Acute and chronic graft-versus-host disease induced by minor histocompatibility antigen in mice. Transplantation 36:150, 1983
8. Claman HN, Jaffee B: Minor antigen graft-versus-host reactions revealed in irradiated spleen and popliteal lymph node assay. Transplantation 38:392, 1984
9. Holda JH, Maier T, Claman HN: Graft-versus-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena. J Immunol 134:1397, 1985
10. Maier T, Holda JH, Claman HN: Graft-versus-host reactions (GVHR) across minor histocompatibility barriers. II. Development of natural suppressor cell activity. J Immunol 135:1644, 1985
11. Huchet R, Bruley-Rosset M, Mathiot Cl, Grandjon D, Halle-Pannenko O: Involvement of IFN-γ and transforming growth factor-ß in graft-vs-host reaction-associated immunosuppression. J Immunol 150:2517, 1993
12. + B cells. Immunol Rev 137:91, 1994
13. Thiele DL, Kurosaka M, Lipsky PE: Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: Delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J Immunol 131:2282, 1983
14. Hoffman RA, Langehr JM, Billiar TR, Curran RD, Simmons RL: Alloantigen induced activation of rat splenocytes is regulated by the oxidative metabolism of L-argmine. J Immunol 145:2220, 1990
15. Hoffman RA, Langehr JM, Wren SM, Dull KE, Ilstad ST, Mc Carthy SA, Simmons RL: Characterization of the immunosuppressive effects of nitric oxide in graft-vs-host disease. J Immunol 151:1508, 1993
16. Krenger W, Falzarano G, Delmonte J Jr, Snyder KM, Byon JCH, Ferrara JLM: Interferon-γ suppresses T-cell proliferation to mitogens via the nitric oxide pathways during experimental acute graft-versus-host disease. Blood 88:1113, 1996
17. Falzarano G, Krenger W, Snyder KM, Delmonte J Jr, Karandikar M, Ferrara JLM: Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-α in mice with acute graft-versus-host disease. Blood 87:2853, 1996
18. Thiele DL, Charley MR, Calomeni JA, Lipsky PE: Lethal graft-vs-host disease across major histocompatibility barriers: Requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells. J Immunol 138:51, 1987
19. Cunningham AJ: Large number of cells in normal mice produce antibody components of isologous erythrocytes. Nature 252:749, 1974
20. Cunningham AJ, Szenberg A: Further improvements in the plaque technique for detecting single antibody forming cells. Immunology 14:599, 1968
21. 15N] nitrate in biologic fluids. Ann Biochem 126:131, 1982
22. Chenais B, Yapo A, Lepoivre M, Tenu JP: High-performance liquid chromatographic analysis of the unusual pathway of oxidation of L-arginine to citrulline and nitric oxide in mammalian cells. J Chromatogr 539:433, 1991
23. Lyons CR, Orloff GJ, Cunningham JM: Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267:6370, 1992
24. Alonso S, Minty A, Banlet Y, Buckingham M: Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol 23:11, 1986
25. Mosmann TR: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
26. Gregory SH, Sagnimeni AJ, Wing EJ: Arginine analogues suppress antigen-specific and nonspecific T lymphocyte proliferation. Cell Immunol 153:527, 1994
27. Sheffler LA, Wink DA, Melillo G, Cox GW: Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J Immunol 155:886, 1995
28. Munder M, Eichmann K, Modolell M: Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: Competitive regulation by CD4+ T cells correlate with Th1/Th2 phenotype. J Immunol 160:5347, 1998
29. Mercolino TJ, Arnold LW, Hawkins LA, Haughton G: Normal mouse peritoneum contains a large number of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes J Exp Med 168:687, 1988
30. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathology, and pharmacology. Pharmacol Rev 43:109, 1991
31. Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL: Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 170:1769, 1989
32. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323, 1997
33. Hibbs JB, Vavrin Z, Taintor RR: L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition of target cells. J Immunol 138:550, 1987
34. Drapier JC, Hibbs JB: Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 140:2829, 1988
35. Lepoivre M, Flaman JM, Henry Y: Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J Biol Chem 267:22994, 1992
36. Lepoivre M, Flaman JM, Bobé P, Lemaire G, Henry Y: Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis in tumor cells by cytotoxic macrophages. J Biol Chem 269:21891, 1994
37. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL: An L-arginine dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 169:1467, 1989
38. Nunes I, Shapiro RL, Rifkin DB: Characterization of latent TGF-β activation by murine peritoneal macrophages. J Immunol 155:1450, 1995
39. Marth T, Strober W, Seder RA, Kelsall BL: Regulation of transforming growth factor-β production by interleukin-12. Eur J Immunol 27:1213, 1997
40. Schindler H, Diefenbach A, Röllinghoff M, Bogdan C: IFN-γ inhibits the production of latent transforming growth factor-β1 by mouse inflammatory macrophages. Eur J Immunol 28:1181, 1998
41. Murakami M, Nakajima K, Yamazaki K, Muraguchi T, Serikawa T, Honjo T: Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J Exp Med 185:791, 1997
42. Worrall NK, Lazenby WD, Misko TP, Lin TS, Rodi CP, Manning PT, Tilton RG, Williamson JR, Ferguson TB: Modulation of in vivo alloreactivity by inhibition of inductible nitric oxide synthase. J Exp Med 181:63, 1995
43. G-monomethyl-L-Arginine. J Exp Med 179:651, 1994
44. Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW: Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation. Blood 84:2363, 1994